Paul Knight
Stock Analyst at Keybanc
(2.39)
# 2,563
Out of 5,072 analysts
139
Total ratings
45.22%
Success rate
-1.77%
Average return
Main Sectors:
Stocks Rated by Paul Knight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WST West Pharmaceutical Services | Maintains: Overweight | $325 → $350 | $277.14 | +26.29% | 12 | Oct 24, 2025 | |
| XGN Exagen | Maintains: Overweight | $12 → $15 | $7.74 | +93.80% | 7 | Oct 14, 2025 | |
| LFCR Lifecore Biomedical | Initiates: Sector Weight | n/a | $7.84 | - | 1 | Sep 4, 2025 | |
| ATR AptarGroup | Initiates: Overweight | $220 | $123.81 | +77.69% | 1 | Sep 4, 2025 | |
| CYRX Cryoport | Upgrades: Overweight | $15 | $9.60 | +56.25% | 9 | Aug 6, 2025 | |
| EHC Encompass Health | Maintains: Overweight | $122 → $135 | $116.25 | +16.13% | 1 | May 27, 2025 | |
| HBIO Harvard Bioscience | Downgrades: Sector Weight | n/a | $0.75 | - | 5 | Apr 9, 2025 | |
| TECH Bio-Techne | Downgrades: Sector Weight | n/a | $64.63 | - | 9 | Apr 9, 2025 | |
| WAT Waters | Upgrades: Overweight | $460 | $407.14 | +12.98% | 5 | Mar 31, 2025 | |
| LAB Standard BioTools | Downgrades: Sector Weight | n/a | $1.43 | - | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $8 | $4.14 | +93.24% | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $132 → $145 | $104.66 | +38.54% | 3 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $420 | $181.94 | +130.85% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $213 → $230 | $87.19 | +163.79% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $33 | $26.68 | +23.69% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $36 | $39.94 | -9.86% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $310 | $228.46 | +35.69% | 9 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $210 → $220 | $171.18 | +28.52% | 7 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $593.25 | - | 6 | Oct 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $35 → $37 | $22.90 | +61.57% | 5 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $3.64 | - | 8 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $4.75 | - | 1 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $154.37 | - | 8 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $36.27 | - | 3 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 → $40 | $11.74 | +240.72% | 6 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $390 → $300 | $178.94 | +67.65% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $250 | $231.80 | +7.85% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $382 → $441 | $115.29 | +282.51% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $222 → $236 | $149.14 | +58.24% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $92 → $99 | $77.94 | +27.02% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $47 → $55 | $11.84 | +364.53% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $47.71 | - | 4 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $80.51 | - | 1 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $129.81 | - | 5 | Oct 23, 2017 |
West Pharmaceutical Services
Oct 24, 2025
Maintains: Overweight
Price Target: $325 → $350
Current: $277.14
Upside: +26.29%
Exagen
Oct 14, 2025
Maintains: Overweight
Price Target: $12 → $15
Current: $7.74
Upside: +93.80%
Lifecore Biomedical
Sep 4, 2025
Initiates: Sector Weight
Price Target: n/a
Current: $7.84
Upside: -
AptarGroup
Sep 4, 2025
Initiates: Overweight
Price Target: $220
Current: $123.81
Upside: +77.69%
Cryoport
Aug 6, 2025
Upgrades: Overweight
Price Target: $15
Current: $9.60
Upside: +56.25%
Encompass Health
May 27, 2025
Maintains: Overweight
Price Target: $122 → $135
Current: $116.25
Upside: +16.13%
Harvard Bioscience
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $0.75
Upside: -
Bio-Techne
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $64.63
Upside: -
Waters
Mar 31, 2025
Upgrades: Overweight
Price Target: $460
Current: $407.14
Upside: +12.98%
Standard BioTools
Feb 27, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $1.43
Upside: -
Feb 12, 2025
Initiates: Overweight
Price Target: $8
Current: $4.14
Upside: +93.24%
Feb 3, 2025
Maintains: Overweight
Price Target: $132 → $145
Current: $104.66
Upside: +38.54%
Jan 23, 2025
Maintains: Overweight
Price Target: $400 → $420
Current: $181.94
Upside: +130.85%
Jan 23, 2025
Maintains: Overweight
Price Target: $213 → $230
Current: $87.19
Upside: +163.79%
Dec 13, 2024
Maintains: Overweight
Price Target: $30 → $33
Current: $26.68
Upside: +23.69%
Nov 5, 2024
Maintains: Overweight
Price Target: $28 → $36
Current: $39.94
Upside: -9.86%
Oct 23, 2024
Maintains: Overweight
Price Target: $290 → $310
Current: $228.46
Upside: +35.69%
Feb 15, 2024
Maintains: Overweight
Price Target: $210 → $220
Current: $171.18
Upside: +28.52%
Oct 26, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $593.25
Upside: -
Aug 30, 2023
Maintains: Overweight
Price Target: $35 → $37
Current: $22.90
Upside: +61.57%
Aug 8, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $3.64
Upside: -
Jul 12, 2023
Initiates: Sector Weight
Price Target: n/a
Current: $4.75
Upside: -
May 24, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $154.37
Upside: -
May 10, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $36.27
Upside: -
Sep 15, 2022
Maintains: Overweight
Price Target: $51 → $40
Current: $11.74
Upside: +240.72%
May 5, 2022
Maintains: Overweight
Price Target: $390 → $300
Current: $178.94
Upside: +67.65%
Apr 28, 2022
Maintains: Overweight
Price Target: $290 → $250
Current: $231.80
Upside: +7.85%
Jan 8, 2021
Maintains: Overweight
Price Target: $382 → $441
Current: $115.29
Upside: +282.51%
Jan 8, 2021
Maintains: Overweight
Price Target: $222 → $236
Current: $149.14
Upside: +58.24%
Jan 8, 2021
Maintains: Overweight
Price Target: $92 → $99
Current: $77.94
Upside: +27.02%
Jan 8, 2021
Maintains: Overweight
Price Target: $47 → $55
Current: $11.84
Upside: +364.53%
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $47.71
Upside: -
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $80.51
Upside: -
Oct 23, 2017
Upgrades: Neutral
Price Target: n/a
Current: $129.81
Upside: -